OCON Therapeutics takes the lead in uterine health advocacy with NIH and Bill and Melinda Gates Foundation
University of Oxford inviting OCON Therapeutics to present at the #AIMday 2022 seminar dedicated to women’s health
Panel Discussion “The Evolution of Birth Control: Considerations from Product Development to End-User Adoption from Leading Innovators”
Contraception Innovation Spotlight WINNER @ The Women’s Health Contraception Innovation Summit February 23rd